CY1120315T1 - Συνδυαστικη θεραπεια για καρκινο των ωοθηκων - Google Patents
Συνδυαστικη θεραπεια για καρκινο των ωοθηκωνInfo
- Publication number
- CY1120315T1 CY1120315T1 CY20181100601T CY181100601T CY1120315T1 CY 1120315 T1 CY1120315 T1 CY 1120315T1 CY 20181100601 T CY20181100601 T CY 20181100601T CY 181100601 T CY181100601 T CY 181100601T CY 1120315 T1 CY1120315 T1 CY 1120315T1
- Authority
- CY
- Cyprus
- Prior art keywords
- ovarian cancer
- cooperative treatment
- treatment
- cooperative
- ylamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει μια μέθοδο θεραπείας του καρκίνου των ωοθηκών σε ένα θηλαστικό που χρειάζεται τέτοια θεραπεία που περιλαμβάνει χορήγηση μιας αποτελεσματικής ποσότητας ενός συνδυασμού γεμσιταβίνης, σισπλατίνης ή καρβοπλατίνης, και 5-[2-tert-βουτυλο-5-(4-φθορο-φαινυλο)-1Η-ιμιδαζολ-4-υλ]-3-(2,2-διμεθυλο-προπυλο)-3Η-ιμιδαζο[4,5-b]πυριδιν-2-υλαμίνης.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161558582P | 2011-11-11 | 2011-11-11 | |
| PCT/US2012/062634 WO2013070460A1 (en) | 2011-11-11 | 2012-10-31 | Combination therapy for ovarian cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1120315T1 true CY1120315T1 (el) | 2019-07-10 |
Family
ID=47146746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181100601T CY1120315T1 (el) | 2011-11-11 | 2018-06-08 | Συνδυαστικη θεραπεια για καρκινο των ωοθηκων |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US9844529B2 (el) |
| EP (1) | EP2780011B1 (el) |
| JP (1) | JP6055481B2 (el) |
| KR (1) | KR101647569B1 (el) |
| CN (1) | CN103917233B (el) |
| AP (1) | AP3881A (el) |
| AU (1) | AU2012336154B2 (el) |
| BR (1) | BR112014011197A2 (el) |
| CA (1) | CA2850559C (el) |
| CR (1) | CR20140211A (el) |
| CY (1) | CY1120315T1 (el) |
| DK (1) | DK2780011T3 (el) |
| DO (1) | DOP2014000100A (el) |
| EA (1) | EA026297B1 (el) |
| ES (1) | ES2671730T3 (el) |
| HR (1) | HRP20180875T1 (el) |
| HU (1) | HUE037928T2 (el) |
| IL (1) | IL232479A0 (el) |
| LT (1) | LT2780011T (el) |
| ME (1) | ME03035B (el) |
| MX (1) | MX2014005698A (el) |
| MY (1) | MY168927A (el) |
| PL (1) | PL2780011T3 (el) |
| PT (1) | PT2780011T (el) |
| RS (1) | RS57256B1 (el) |
| SG (1) | SG11201401795XA (el) |
| SI (1) | SI2780011T1 (el) |
| TN (1) | TN2014000150A1 (el) |
| WO (1) | WO2013070460A1 (el) |
| ZA (1) | ZA201403159B (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106659765B (zh) | 2014-04-04 | 2021-08-13 | 德玛医药 | 二脱水半乳糖醇及其类似物或衍生物用于治疗非小细胞肺癌和卵巢癌的用途 |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| WO2019071147A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1356872A (zh) | 1998-12-31 | 2002-07-03 | 苏根公司 | 调节蛋白激酶活性和用于癌症化疗的3－亚杂芳基－2－吲哚满酮化合物 |
| TWI332003B (en) * | 2004-01-30 | 2010-10-21 | Lilly Co Eli | Kinase inhibitors |
-
2012
- 2012-10-31 CN CN201280054290.7A patent/CN103917233B/zh not_active Expired - Fee Related
- 2012-10-31 WO PCT/US2012/062634 patent/WO2013070460A1/en active Application Filing
- 2012-10-31 BR BR112014011197A patent/BR112014011197A2/pt not_active IP Right Cessation
- 2012-10-31 DK DK12783804.3T patent/DK2780011T3/en active
- 2012-10-31 MX MX2014005698A patent/MX2014005698A/es unknown
- 2012-10-31 KR KR1020147012229A patent/KR101647569B1/ko active IP Right Grant
- 2012-10-31 PT PT127838043T patent/PT2780011T/pt unknown
- 2012-10-31 PL PL12783804T patent/PL2780011T3/pl unknown
- 2012-10-31 EA EA201490766A patent/EA026297B1/ru not_active IP Right Cessation
- 2012-10-31 SG SG11201401795XA patent/SG11201401795XA/en unknown
- 2012-10-31 AP AP2014007631A patent/AP3881A/en active
- 2012-10-31 MY MYPI2014701157A patent/MY168927A/en unknown
- 2012-10-31 ME MEP-2018-132A patent/ME03035B/me unknown
- 2012-10-31 LT LTEP12783804.3T patent/LT2780011T/lt unknown
- 2012-10-31 ES ES12783804.3T patent/ES2671730T3/es active Active
- 2012-10-31 US US14/354,244 patent/US9844529B2/en not_active Expired - Fee Related
- 2012-10-31 AU AU2012336154A patent/AU2012336154B2/en not_active Ceased
- 2012-10-31 SI SI201231285T patent/SI2780011T1/en unknown
- 2012-10-31 JP JP2014541100A patent/JP6055481B2/ja not_active Expired - Fee Related
- 2012-10-31 RS RS20180602A patent/RS57256B1/sr unknown
- 2012-10-31 HU HUE12783804A patent/HUE037928T2/hu unknown
- 2012-10-31 EP EP12783804.3A patent/EP2780011B1/en active Active
- 2012-10-31 CA CA2850559A patent/CA2850559C/en not_active Expired - Fee Related
-
2014
- 2014-04-10 TN TNP2014000150A patent/TN2014000150A1/en unknown
- 2014-04-30 ZA ZA2014/03159A patent/ZA201403159B/en unknown
- 2014-05-05 IL IL232479A patent/IL232479A0/en unknown
- 2014-05-09 CR CR20140211A patent/CR20140211A/es unknown
- 2014-05-09 DO DO2014000100A patent/DOP2014000100A/es unknown
-
2018
- 2018-06-05 HR HRP20180875TT patent/HRP20180875T1/hr unknown
- 2018-06-08 CY CY20181100601T patent/CY1120315T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124926T1 (el) | Νανοσωματιδια που περιλαμβανουν σιρολιμους και μια αλβουμινη για χρηση στη θεραπεια ογκων απο επιθηλιοειδη κυτταρα | |
| PH12019501393A1 (en) | Afucosylated anti-fgfr2iiib antibodies | |
| CY1124798T1 (el) | Υποκατεστημενα παραγωγα καρβονουκλεοζιδιων χρησιμα ως παραγοντες κατα των καρκινων | |
| BR112015007184A2 (pt) | combinação de anticorpos anti-kir e anticorpos anti-pd-1 para tratar câncer | |
| BR112018067368A2 (pt) | terapia de combinação com anticorpos anti-cd73 | |
| EA201391626A1 (ru) | Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака | |
| CY1120536T1 (el) | Μεθοδος και συνθεσεις για τη θεραπευτικη αγωγη του καρκινου | |
| EA201890159A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ ГЕМАТОЛОГИЧЕСКОГО ЗЛОКАЧЕСТВЕННОГО НОВООБРАЗОВАНИЯ С ПОМОЩЬЮ КОМБИНИРОВАННОЙ ТЕРАПИИ ИНГИБИТОРОМ mTOR В ВИДЕ НАНОЧАСТИЦ | |
| TR201812261T4 (tr) | Pi3 ki̇naz i̇zoform modülatörleri̇ i̇le kanser tedavi̇si̇ | |
| EA201890754A1 (ru) | Соединения и способы их применения | |
| MX2015008888A (es) | Metodo para tratar el cancer basado en el nivel de un transportador de nucleosido. | |
| EA201990296A1 (ru) | Антитела против siglec-7 для лечения рака | |
| CY1122074T1 (el) | Νεα παραγωγα 3'-δεοξυαδενοσινης του φωσφοραμαδικου εστερα toy 2' και/η 5' aminoξεος ως αντικαρκινικες ενωσεις | |
| MX2017002852A (es) | Activacion de linfocitos que infiltran la medula en condiciones hipoxicas alternando con normoxicas. | |
| BR112014013150A2 (pt) | benzimidazoles e benzopirazoles substituídas como antagonistas de ccr(4) | |
| EA201171367A1 (ru) | Винилиндазолильные соединения | |
| IN2014CN02501A (el) | ||
| EA201890768A3 (ru) | Лечение злокачественной опухоли ингибиторами tor-киназы | |
| CY1121821T1 (el) | Θεραπεια συνδυασμου για την αγωγη του καρκινου των ωοθηκων | |
| CY1120315T1 (el) | Συνδυαστικη θεραπεια για καρκινο των ωοθηκων | |
| CY1120877T1 (el) | Συνθεσεις και μεθοδοι για την αντιμετωπιση της κοιλιοκακης | |
| MX2019002728A (es) | Combinacion de un anticuerpo anti-cd20, inhibidor de quinasa pi3-delta, y anticuerpo anti-pd-1 o anti-pd-l1 para el tratamiento hematologico de los canceres. | |
| MX2016015378A (es) | Uso de eribulina en el tratamiento de cancer. | |
| EA201891527A1 (ru) | Композиции и способы обнаружения и лечения рака пищевода | |
| CY1117438T1 (el) | Μεθοδος για την προληψη και την θεραπευτικη αντιμετωπιση της σηψης |